cyc 202 has been researched along with remifentanil in 1 studies
| Studies (cyc 202) | Trials (cyc 202) | Recent Studies (post-2010) (cyc 202) | Studies (remifentanil) | Trials (remifentanil) | Recent Studies (post-2010) (remifentanil) |
|---|---|---|---|---|---|
| 979 | 7 | 393 | 3,830 | 1,644 | 1,886 |
| Protein | Taxonomy | cyc 202 (IC50) | remifentanil (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 0.0006 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, X; Liu, X; Liu, Y; Ma, Z; Sun, YE; Zhang, J; Zhang, W | 1 |
1 other study(ies) available for cyc 202 and remifentanil
| Article | Year |
|---|---|
Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
Topics: Analgesics, Opioid; Animals; Cyclin-Dependent Kinase 5; Hyperalgesia; Injections, Spinal; Male; Motor Activity; Pain Threshold; Pain, Postoperative; Phosphorylation; Piperidines; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, N-Methyl-D-Aspartate; Remifentanil; Roscovitine; Spinal Cord | 2014 |